347 related articles for article (PubMed ID: 25847880)
1. [Evaluation of a new polyvalent antivenom against snakebite envenomation (Inoserp® Panafricain) in two different epidemiological settings: Northern Benin and Maritime Guinea].
Chippaux JP; Baldé MC; Sessinou É; Yéro Boiro M; Massougbodji A
Med Sante Trop; 2015; 25(1):56-64. PubMed ID: 25847880
[TBL] [Abstract][Full Text] [Related]
2. [Clinical study of tolerance and effectiveness of a F(ab')(2) polyvalent antienom for African snake bites in Kindia, Guinea].
Baldé MC; Chippaux JP; Boiro MY; Stock R; Massougbodji A
Bull Soc Pathol Exot; 2012 Aug; 105(3):157-61. PubMed ID: 22359185
[TBL] [Abstract][Full Text] [Related]
3. [Assessment of a therapeutic protocol for the management of snakebite envenomations in Benin].
Tankpinou Zoumenou H; Chippaux JP; Fachehoun P; Priuli G; Massougbodji A
Med Trop Sante Int; 2023 Dec; 3(4):. PubMed ID: 38390023
[TBL] [Abstract][Full Text] [Related]
4. Clinical trial of an F(ab')2 polyvalent equine antivenom for African snake bites in Benin.
Chippaux JP; Massougbodji A; Stock RP; Alagon A;
Am J Trop Med Hyg; 2007 Sep; 77(3):538-46. PubMed ID: 17827375
[TBL] [Abstract][Full Text] [Related]
5. Antivenom use, premedication and early adverse reactions in the management of snake bites in rural Papua New Guinea.
Williams DJ; Jensen SD; Nimorakiotakis B; Müller R; Winkel KD
Toxicon; 2007 May; 49(6):780-92. PubMed ID: 17210167
[TBL] [Abstract][Full Text] [Related]
6. Comparison of F(ab')2 versus Fab antivenom for pit viper envenomation: a prospective, blinded, multicenter, randomized clinical trial.
Bush SP; Ruha AM; Seifert SA; Morgan DL; Lewis BJ; Arnold TC; Clark RF; Meggs WJ; Toschlog EA; Borron SW; Figge GR; Sollee DR; Shirazi FM; Wolk R; de Chazal I; Quan D; García-Ubbelohde W; Alagón A; Gerkin RD; Boyer LV
Clin Toxicol (Phila); 2015 Jan; 53(1):37-45. PubMed ID: 25361165
[TBL] [Abstract][Full Text] [Related]
7. Continuous IV Crotalidae Polyvalent Immune Fab (Ovine) (FabAV) for selected North American rattlesnake bite patients.
Bush SP; Seifert SA; Oakes J; Smith SD; Phan TH; Pearl SR; Reibling ET
Toxicon; 2013 Jul; 69():29-37. PubMed ID: 23474267
[TBL] [Abstract][Full Text] [Related]
8. The Efficacy of Crotalidae Polyvalent Immune Fab (Ovine) Antivenom Versus Placebo Plus Optional Rescue Therapy on Recovery From Copperhead Snake Envenomation: A Randomized, Double-Blind, Placebo-Controlled, Clinical Trial.
Gerardo CJ; Quackenbush E; Lewis B; Rose SR; Greene S; Toschlog EA; Charlton NP; Mullins ME; Schwartz R; Denning D; Sharma K; Kleinschmidt K; Bush SP; Ryan S; Gasior M; Anderson VE; Lavonas EJ
Ann Emerg Med; 2017 Aug; 70(2):233-244.e3. PubMed ID: 28601268
[TBL] [Abstract][Full Text] [Related]
9. Recurrent neurotoxic envenoming of cobra bite.
Tongpoo A; Trakulsrichai S; Putichote K; Sriapha C; Wananukul W
Toxicon; 2019 Sep; 167():180-183. PubMed ID: 31129162
[TBL] [Abstract][Full Text] [Related]
10. Use of polyvalent equine anti-viper serum to treat delayed coagulopathy due to suspected Sistrurus miliarius streckeri envenomation in two children.
Williams KL; Woslager M; Garland SL; Barton RP; Banner W
Clin Toxicol (Phila); 2017 Jun; 55(5):326-331. PubMed ID: 28165801
[TBL] [Abstract][Full Text] [Related]
11. Specific antivenom for Bungarus candidus.
Leeprasert W; Kaojarern S
J Med Assoc Thai; 2007 Jul; 90(7):1467-76. PubMed ID: 17710993
[TBL] [Abstract][Full Text] [Related]
12. Snakebites in Cameroon: Tolerance of a Snake Antivenom (Inoserp™ PAN-AFRICA) in Africa in Real-Life Conditions.
Benhammou D; Chippaux JP; Ntone R; Madec Y; Amta P; Noel G; Karl FN; Perilhou A; Matchim L; Sanchez M; Ndifon M; Clauteaux P; Eteki L; Boum Y; Nkwescheu AS; Taieb F
Toxins (Basel); 2024 Mar; 16(4):. PubMed ID: 38668590
[TBL] [Abstract][Full Text] [Related]
13. Crotalidae polyvalent immune Fab: in patients with North American crotaline envenomation.
Keating GM
BioDrugs; 2011 Apr; 25(2):69-76. PubMed ID: 21443271
[TBL] [Abstract][Full Text] [Related]
14. Clinical effects and treatment of envenoming by Hoplocephalus spp. snakes in Australia: Australian Snakebite Project (ASP-12).
Isbister GK; White J; Currie BJ; O'Leary MA; Brown SG;
Toxicon; 2011 Dec; 58(8):634-40. PubMed ID: 21967812
[TBL] [Abstract][Full Text] [Related]
15. Subacute coagulopathy in a randomized, comparative trial of Fab and F(ab')2 antivenoms.
Boyer LV; Chase PB; Degan JA; Figge G; Buelna-Romero A; Luchetti C; Alagón A
Toxicon; 2013 Nov; 74():101-8. PubMed ID: 23948058
[TBL] [Abstract][Full Text] [Related]
16. Snakebite by the Shore Pit Viper (Trimeresurus purpureomaculatus) Treated With Polyvalent Antivenom.
Mong R; Tan HH
Wilderness Environ Med; 2016 Jun; 27(2):266-70. PubMed ID: 27061038
[TBL] [Abstract][Full Text] [Related]
17. Acute adverse events associated with the administration of Crotalidae polyvalent immune Fab antivenom within the North American Snakebite Registry.
Kleinschmidt K; Ruha AM; Campleman S; Brent J; Wax P;
Clin Toxicol (Phila); 2018 Nov; 56(11):1115-1120. PubMed ID: 29688079
[No Abstract] [Full Text] [Related]
18. Coral snake bites (Micrurus spp.) in Brazil: a review of literature reports.
Bucaretchi F; Capitani EM; Vieira RJ; Rodrigues CK; Zannin M; Da Silva NJ; Casais-e-Silva LL; Hyslop S
Clin Toxicol (Phila); 2016 Mar; 54(3):222-34. PubMed ID: 26808120
[TBL] [Abstract][Full Text] [Related]
19. Clinical safety of a polyvalent F(ab')2 equine antivenom in 223 African snake envenomations: a field trial in Cameroon. VAO (Venin Afrique de l'Ouest) Investigators.
Chippaux JP; Lang J; Eddine SA; Fagot P; Rage V; Peyrieux JC; Le Mener V
Trans R Soc Trop Med Hyg; 1998; 92(6):657-62. PubMed ID: 10326114
[TBL] [Abstract][Full Text] [Related]
20. A prospective multicenter observational study of Viperidae polyvalent immune F(ab')
Vanni M; Intorre L; Corazza M; Meucci V; Parti S
J Vet Emerg Crit Care (San Antonio); 2020 Jan; 30(1):34-40. PubMed ID: 31858721
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
